Non-Small Cell Lung Cancer (NSCLC)
Conditions
Interventions
High Altitude Group:NA
Low Altitude Group:NA
Sponsors
Xi'an Jiaotong University Second Affiliated Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 years or older, regardless of gender. 2. Diagnosed with primary non-small cell lung cancer (NSCLC) confirmed by clear cytological or histopathological evidence. 3. Receiving antitumor immunotherapy for the first time. 4. At least one efficacy evaluation during the treatment period. 5. Voluntarily participating in the study with a strong willingness to cooperate.
Exclusion criteria
Exclusion criteria: 1. Unknown histopathological type. 2. Missing records of antitumor treatment information, or participation in blinded drug clinical trials resulting in unclear medication details. 3. Concurrent malignant tumors that have not been radically resected. 4. Previous treatment with immunotherapies other than immune checkpoint inhibitors. 5. Patients unwilling to participate in the study or with a poor willingness to cooperate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-Free Survival (PFS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Event-Free Survival (EFS);Overall Survival (OS);Disease-Free Survival (DFS);Pathological Complete Response (PCR);Objective Response Rate (ORR);Metastasis;Immune-Related Adverse Events (irAEs);Treatment-Related Adverse Events (TRAE);Serious Adverse Event (SAE);Major Pathological Response (MPR); | — |
Countries
China
Contacts
Public ContactGuo hui
Xi'an Jiaotong University Second Affiliated Hospital
Outcome results
None listed